Roxann Guerrette

Director, Business Development at NUMAFERM
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Boston, Massachusetts, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Business Development Foundations
    LinkedIn
    Jan, 2022
    - Nov, 2024
  • Developing Your Emotional Intelligence
    LinkedIn
    Jan, 2022
    - Nov, 2024
  • Leadership for Drug Development Teams
    Tufts Center for the Study of Drug Development
    Oct, 2021
    - Nov, 2024

Experience

    • Germany
    • Biotechnology Research
    • 1 - 100 Employee
    • Director, Business Development
      • Sep 2023 - Present

      Establishing a Boston office and identifying growth opportunities, forging strategic partnerships, as well as expanding the company's market presence. Lead the development and execution of strategies to drive revenue growth, involving market research, sales and marketing collaboration, and financial analysis. Numaferm is a trusted partner in the field of the recombinant expression of peptides, pepteins and proteins. Pepteins are made of 41-100 aa and combine the advantages of peptides (≤ 40 aa; good permeability, low immunogenicity) with those of proteins (> 100 aa; high affinities, potencies, specificities and/or stabilities). Show less

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Director, Business Development
      • Mar 2023 - Aug 2023

      US brand building and discovering expansion opportunities, creating important partnerships, and growing the company's market reach. Taking charge of developing and implementing plans to boost revenue, which includes researching the market, collaborating with sales and marketing, and analyzing finances. Catalog selection of 2500+ ready-made recombinant proteins includes various targets, species, tags, and labels. US brand building and discovering expansion opportunities, creating important partnerships, and growing the company's market reach. Taking charge of developing and implementing plans to boost revenue, which includes researching the market, collaborating with sales and marketing, and analyzing finances. Catalog selection of 2500+ ready-made recombinant proteins includes various targets, species, tags, and labels.

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Alliance and Project Manager
      • Jan 2022 - Mar 2023

      Liaison between partners and laboratory scientists at Twist. Involves the design, planning, and coordination of therapeutic antibody development campaigns, including direct management of a portfolio of projects, partner communications, and interaction with scientific teams. Liaison between partners and laboratory scientists at Twist. Involves the design, planning, and coordination of therapeutic antibody development campaigns, including direct management of a portfolio of projects, partner communications, and interaction with scientific teams.

    • United States
    • Biotechnology
    • 1 - 100 Employee
    • Senior Scientist III, Project Leader, Biosafety Officer, ELN Integration Officer
      • Apr 2020 - Jan 2022

      Phage display. library construction. SCFV and VHH. Bispecific antibodiy engineering. ADCs. CAR-T. Patents : CA3190328A1, CA3185858A1, AR122514A1, AR123086A1, AR123628A1 Clinical trial: DC-6001-101, NCT05496595 Phage display. library construction. SCFV and VHH. Bispecific antibodiy engineering. ADCs. CAR-T. Patents : CA3190328A1, CA3185858A1, AR122514A1, AR123086A1, AR123628A1 Clinical trial: DC-6001-101, NCT05496595

  • MIT
    • Boston, Massachusetts, United States
    • Judge at Pandemic Respond Collab
      • Nov 2020 - Mar 2021

      How can we stop infectious diseases from spreading? Large-scale, rapid testing and continuous disease monitoring play a crucial role in containing pandemics. Establishing early warning detection systems could be one way of tackling this How can we stop infectious diseases from spreading? Large-scale, rapid testing and continuous disease monitoring play a crucial role in containing pandemics. Establishing early warning detection systems could be one way of tackling this

    • Expert Panel
      • Feb 2020 - Jan 2021

      Search engine and online platform for COVID-19 misinformation and propaganda mitigation Search engine and online platform for COVID-19 misinformation and propaganda mitigation

    • United States
    • Biotechnology
    • 1 - 100 Employee
    • Protein Engineer
      • Nov 2018 - May 2019

      Mitacs Accelerate International collaboration for creation of research tools DistributedBio was acquired by Charles River in December 2020. Mitacs Accelerate International collaboration for creation of research tools DistributedBio was acquired by Charles River in December 2020.

    • France
    • Hospitals and Health Care
    • 400 - 500 Employee
    • Proteomics Marseille
      • Dec 2017 - Jun 2018

      Mitacs Globalink international collaboration at Paoli-Calmettes' proteomic platform with Orbitrap Fusion Lumos Mitacs Globalink international collaboration at Paoli-Calmettes' proteomic platform with Orbitrap Fusion Lumos

    • Project Manager
      • Oct 2015 - Apr 2016

      The New Brunswick Breast and Women’s Cancer Partnership (NBBWCP) brings bilingual information and support straight into the homes of women diagnosed with breast, ovarian, cervical and uterine cancer in New Brunswick. Our mission is to support women by empowering them to make informed decisions, and by engaging networks to foster a community of support. The New Brunswick Breast and Women’s Cancer Partnership (NBBWCP) brings bilingual information and support straight into the homes of women diagnosed with breast, ovarian, cervical and uterine cancer in New Brunswick. Our mission is to support women by empowering them to make informed decisions, and by engaging networks to foster a community of support.

Education

  • Quantic School of Business and Technology
    Executive MBA
    2023 - 2024
  • Université de Montréal
    Entrepreneurship in Oncology, Life Science
  • Université de Moncton
    PhD Life Science, Breast Cancer
  • Dalhousie University
    CCAC Laboratory Animals for Research, Oncology and Cancer Biology
  • Université de Moncton
    Masters, Biochemistry
  • Collège La Cité
    Bachelor's degree, Biotechnology

Community

You need to have a working account to view this content. Click here to join now